减肥因克列模仿剂 宽恕不坚持
Anıl Cengiz1, Calvin C Wu2, Sean D Lawley1
1Department of Mathematics, University of Utah, Salt Lake City, Utah, USA.
Diabetes, obesity & metabolism
|May 14, 2025
概括
像GLP-1激动剂这样的减肥药即使错过了剂量也有效. 研究表明,即使患者仅服用处方用因克雷仿效剂量的一半,仍有可能显著减肥.
科学领域:
- 药理学和内分泌学 药理学和内分泌学
- 肥胖医学 肥胖医学
- 医学中的数学建模.
背景情况:
- 葡萄糖类-1 (GLP-1) 和依赖葡萄糖的胰岛素托普多 (GIP) -GLP-1激动剂是强效的减肥药物.
- 较低的患者坚持是因克雷丁模拟剂的常见挑战,可能会限制临床疗效.
- 定义"适当"的坚持对于最大限度地提高治疗结果至关重要.
研究的目的:
- 为了研究不完美的粘附对因克雷丁模仿剂减肥功效的影响.
- 为了确定临床上有意义的减肥所需的坚持值,使用这些药物.
主要方法:
- 利用数学建模和随机模拟来分析在非粘附条件下减肥的有效性.
- 采用经过验证的药理动力学和药理动力学模型,用于赛马格卢提德和蒂尔泽帕提德.
- 通过随机省略剂量模拟患者的坚持.
主要成果:
- 塞马格卢提德和蒂尔泽帕提德证明了不坚持的宽恕,尽管错过了剂量,但仍然保持了显著的减肥效果.
- 达到80%的坚持会导致大约90%的体重减轻在完美的坚持下.
- 即使是50%的坚持也会产生近70%的体重减轻在完美的坚持下实现的体重减轻,体重波动最小.
结论:
- 英克雷丁模仿剂在肥胖管理中非常有效,即使依附度低于最佳水平.
- 对于这些药物来说,对于显著的体重减轻而言,传统的80%的遵守要求可能需要重新评估.
相关概念视频
Glucagon-like Receptor Agonists
270
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
270
Dipeptidyl Peptidase 4 Inhibitors
136
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
136
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
125
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
125
Oral Hypoglycemic Agents: Glinides
111
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
111
Oral Hypoglycemic Agents: Biguanides and Glitazones
141
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
141
Regulation of Food Intake
150
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
150


